Veterinary Medicines

Zantel Cat and Dog Tablets

Authorised
  • Praziquantel
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Zantel Cat and Dog Tablets
Active substance:
  • Praziquantel
  • Fenbendazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Fenbendazole
    500.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 120 tablets.Strips: 120 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 100 tablets.Strips: 100 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 60 tablets.Strips: 60 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 50 tablets.Strips: 50 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 48 tablets.Strips: 48 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 30 tablets.Strips: 30 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 24 tablets.Strips: 24 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 20 tablets.Strips: 20 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 12 tablets.Strips: 12 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 10 tablets.Strips: 10 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 8 tablets.Strips: 8 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 4 tablets.Strips: 4 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 3 tablets.Strips: 3 tablets
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene.3. Foil blisters (aluminium/aluminium).Blisters: 2 tablets.Strips: 2 tablets
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 120 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 100 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 96 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 60 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 50 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 30 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 24 tablets.
  • 1. White high density polyethylene (HDPE) containers with a white polypropylene child resistant tamper evident cap.Containers: 20 tablets.
  • 2. 30µ aluminium foil coated with 35 gsm extruded polythene. 3. Foil blisters (aluminium/aluminium). Blisters: 96 tablets. Strips: 96 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Ltd
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/052/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
Average: 1 (3 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."